Growth Metrics

Bioventus (BVS) Income from Continuing Operations (2020 - 2025)

Historic Income from Continuing Operations for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $4.0 million.

  • Bioventus' Income from Continuing Operations rose 16850.21% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year increase of 12323.2%. This contributed to the annual value of -$43.8 million for FY2024, which is 6383.3% up from last year.
  • Bioventus' Income from Continuing Operations amounted to $4.0 million in Q3 2025, which was up 16850.21% from $9.3 million recorded in Q2 2025.
  • Bioventus' Income from Continuing Operations' 5-year high stood at $24.5 million during Q2 2021, with a 5-year trough of -$101.0 million in Q4 2022.
  • Over the past 5 years, Bioventus' median Income from Continuing Operations value was -$6.4 million (recorded in 2024), while the average stood at -$15.2 million.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first crashed by 8580800.0% in 2022, then soared by 16850.21% in 2025.
  • Over the past 5 years, Bioventus' Income from Continuing Operations (Quarter) stood at -$25000.0 in 2021, then tumbled by 85808.0% to -$21.5 million in 2022, then skyrocketed by 64.35% to -$7.7 million in 2023, then surged by 134.13% to $2.6 million in 2024, then skyrocketed by 53.31% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $9.3 million for Q2 2025, and -$3.3 million during Q1 2025.